{
    "clinical_study": {
        "@rank": "50363", 
        "arm_group": [
            {
                "arm_group_label": "Diet plus branched chain aminoacids", 
                "arm_group_type": "Experimental", 
                "description": "High-fiber high-protein diet Oral supplement : branched chain aminoacids"
            }, 
            {
                "arm_group_label": "Diet", 
                "arm_group_type": "Active Comparator", 
                "description": "High-fiber high-protein diet"
            }
        ], 
        "brief_summary": {
            "textblock": "Malnutrition is a frequent complication in patients with liver cirrhosis. Most patients have\n      decreased dietary intake due to ascites, hepatic encephalopathy and pro-inflammatory\n      cytokines.\n\n      We hypothesized that branched chain aminoacids can improve nutritional status and delay\n      episodes of hepatic encephalopathy"
        }, 
        "brief_title": "Branched Chain Aminoacid Supplementation in Patients With Liver Cirrhosis", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Liver Cirrhosis", 
        "condition_browse": {
            "mesh_term": [
                "Liver Cirrhosis", 
                "Fibrosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Ambulatory patients Patients with confirmed diagnose of liver cirrhosis Patients\n        classified as Child-Pugh A or Child Pugh B\n\n        Exclusion Criteria:\n\n        Acute or chronic renal failure Pregnancy Overt hepatic encephalopathy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "68", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02023229", 
            "org_study_id": "Enterex01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Diet plus branched chain aminoacids", 
                "intervention_name": "Branched-chain aminoacids", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": [
                    "Diet plus branched chain aminoacids", 
                    "Diet"
                ], 
                "intervention_name": "High-fiber high protein diet", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Branched chain aminoacids", 
            "Nutritional status", 
            "Hepatic encephalopathy"
        ], 
        "lastchanged_date": "December 23, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Mexico city", 
                    "country": "Mexico", 
                    "zip": "14000"
                }, 
                "name": "Instituto Nacional de Ciencias M\u00e9dicas y Nutrici\u00f3n \"Salvador Zubir\u00e1n\""
            }
        }, 
        "location_countries": {
            "country": "Mexico"
        }, 
        "number_of_arms": "2", 
        "official_title": "High-fiber High-fiber Diet and Branched Chain Aminoacids. Impact on Nutritional Status and Complications in Patients With Liver Cirrhosis", 
        "other_outcome": [
            {
                "description": "Assessed by bioelectrical impedance vector analysis and mid-arm muscle circumference", 
                "measure": "Nutritional status", 
                "safety_issue": "No", 
                "time_frame": "3 months follow-up"
            }, 
            {
                "description": "Assessed by bioelectrical impedance vector analysis and mid-arm muscle circumference", 
                "measure": "Nutritional status", 
                "safety_issue": "No", 
                "time_frame": "6 months follow-up"
            }, 
            {
                "measure": "Hepatic encephalopathy", 
                "safety_issue": "No", 
                "time_frame": "6 months follow-up"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Mexico: Secretaria de Salud", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Assessed by bioelectrical impedance vector analysis and mid-arm muscle circumference", 
            "measure": "Nutritional status", 
            "safety_issue": "No", 
            "time_frame": "At time of recruitment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02023229"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran", 
            "investigator_full_name": "ALDO TORRE DELGADILLO", 
            "investigator_title": "Principal investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Hepatic Encephalopathy", 
            "safety_issue": "No", 
            "time_frame": "At time of recruitment"
        }, 
        "source": "Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}